Presentations

  • 2023 - 24

    08 Jan

    Investor’s Presentation_42nd Annual JP Morgan Healthcare Conference

    06 Jan

    Investor Update on PROSEEK Program

    02 Nov

    Update on Clinical Programs and R&D Pipeline

  • 2022 - 23

    13 Oct

    Update on clinical programs and R&D pipeline

    08 Jul

    Corporate Presentation

  • 2021 -22

    28 Dec

    Corporate Presentation

    09 Dec

    Update on SPARC strategy and portfolio

    05 Jan

    Corporate Presentation

  • 2020 - 21

    10 Sep
  • 2019 - 20

    19 Sep
  • 2018 - 19

    04 Sep
  • 2017 - 16

    09 Oct

    Update on Baclofen GRS Phase III program

    24 Aug
  • 2016 - 17

    04 Aug
  • 2015 - 16

    10 Jun

    Update on NCE and NDDS programs

  • 2014 -15

    26 Feb

    Update on NCE and NDDS programs

  • 2023 - 24

    08 Jan

    Investor’s Presentation_42nd Annual JP Morgan Healthcare Conference

    06 Jan

    Investor Update on PROSEEK Program

    02 Nov

    Update on Clinical Programs and R&D Pipeline

  • 2022 - 23

    13 Oct

    Update on clinical programs and R&D pipeline

    08 Jul

    Corporate Presentation

  • 2021 -22

    28 Dec

    Corporate Presentation

    09 Dec

    Update on SPARC strategy and portfolio

    05 Jan

    Corporate Presentation

  • 2020 - 21

    10 Sep
  • 2019 - 20

    19 Sep
  • 2018 - 19

    04 Sep
  • 2017 - 16

    09 Oct

    Update on Baclofen GRS Phase III program

    24 Aug
  • 2016 - 17

    04 Aug
  • 2015 - 16

    10 Jun

    Update on NCE and NDDS programs

  • 2014 -15

    26 Feb

    Update on NCE and NDDS programs

Copyright @ 2024. All Rights Reserved.
Follow Us :